Copyright © 2000 by the European Society of Cardiology.
Hotline Editorial
Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverterdefibrillator
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, U.S.A.
References
- Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997;350:127133[CrossRef][ISI][Medline]
- Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995;92:16801692
[Free Full Text] - Spirito P, Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775785
[Free Full Text] - Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: Interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316:780789[ISI][Medline]
- Teare D. Asymmetrical hypertrophy of the heart in young patients. Br Heart J. 1958;20:18
[Free Full Text] - McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: An important cause of sudden death. Arch Dis Child. 1984;59:971975[Abstract]
- Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: Profile of 78 patients. Circulation. 1982;65:13881394
[Abstract/Free Full Text] - Maron, BJ, Olivotto, I, Spirito, P, Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral based patient population, Circulation
- Maron BJ, Spirito P. Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol. 1993;72:970972[CrossRef][ISI][Medline]
- Spirito P, Rapezzi C, Autore C. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation. 1994;90:27432747
[Abstract/Free Full Text] - Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:20442051
[Abstract/Free Full Text] - Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol. 1981;48:252257[CrossRef][ISI][Medline]
- McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk. Circulation. 1989;80:14891492
[Free Full Text] - Maron BJ, Shen W-K, Link MS. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000;342:365373
[Abstract/Free Full Text] - McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 1985;53:412416
[Abstract/Free Full Text] - Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med. 1988;318:12551256[ISI][Medline]
- Mirowski M, Reid PR, Mower MM. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322324[ISI][Medline]
- N Engl J Med. 1997;337:15761583
[Abstract/Free Full Text] - Moss AJ, Hall WJ, Cannom DS. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:19331940
[Abstract/Free Full Text] - Moss AJ, Daubert JP. Internal ventricular defibrillation. N Engl J Med. 2000;342:398
[Free Full Text] - Cecchi F, Maron BJ, Epstein SE. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol. 1989;13:12831288[Abstract]
- Maron BJ, Gross BW, Stark SI. Extreme left ventricular hypertrophy. Circulation. 1995;92:2748
[Free Full Text] - Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli D. Clinical consequences of hypertrophic cardiomyopathy in an unselected regional United States cohort. JAMA. 1999;281:650655
[Abstract/Free Full Text] - Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation. 1979;59:689706
[Free Full Text] - Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ. Survival after cardiac arrest in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 1999;33:15961601
[Abstract/Free Full Text] - Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26:16991708[Abstract]
This article has been cited by other articles:
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
C Hengstenberg, J Erdmann, and P Charron Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: Prediction of clinical status--is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice? Cardiovasc Res, February 1, 2003; 57(2): 298 - 301. [Full Text] [PDF] |
||||
![]() |
R. Roberts and U. Sigwart New Concepts in Hypertrophic Cardiomyopathies, Part II Circulation, October 30, 2001; 104(18): 2249 - 2252. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



